Ultralife Corporation
Ultralife Corporation Fundamental Analysis
Ultralife Corporation (ULBI) shows moderate financial fundamentals with a PE ratio of -17.96, profit margin of -3.09%, and ROE of -4.35%. The company generates $0.2B in annual revenue with moderate year-over-year growth of 3.66%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 24.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ULBI's fundamental strength across five key dimensions:
Efficiency Score
WeakULBI struggles to generate sufficient returns from assets.
Valuation Score
ExcellentULBI trades at attractive valuation levels.
Growth Score
WeakULBI faces weak or negative growth trends.
Financial Health Score
ExcellentULBI maintains a strong and stable balance sheet.
Profitability Score
WeakULBI struggles to sustain strong margins.
Key Financial Metrics
Is ULBI Expensive or Cheap?
P/E Ratio
ULBI trades at -17.96 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ULBI's PEG of 0.04 indicates potential undervaluation.
Price to Book
The market values Ultralife Corporation at 0.81 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.57 times EBITDA. This is generally considered low.
How Well Does ULBI Make Money?
Net Profit Margin
For every $100 in sales, Ultralife Corporation keeps $-3.09 as profit after all expenses.
Operating Margin
Core operations generate 3.28 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-4.35 in profit for every $100 of shareholder equity.
ROA
Ultralife Corporation generates $-2.72 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Ultralife Corporation generates limited operating cash flow of $12.52M, signaling weaker underlying cash strength.
Free Cash Flow
Ultralife Corporation produces free cash flow of $8.92M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.54 in free cash annually.
FCF Yield
ULBI converts 8.29% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-17.96
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.04
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.81
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.55
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.38
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.83
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.04
vs 25 benchmark
ROA
Return on assets percentage
-0.03
vs 25 benchmark
ROCE
Return on capital employed
0.03
vs 25 benchmark
How ULBI Stacks Against Its Sector Peers
| Metric | ULBI Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -17.96 | 25.84 | Better (Cheaper) |
| ROE | -4.35% | 1279.00% | Weak |
| Net Margin | -3.09% | -43714.00% (disorted) | Weak |
| Debt/Equity | 0.38 | 0.80 | Strong (Low Leverage) |
| Current Ratio | 2.83 | 10.62 | Strong Liquidity |
| ROA | -2.72% | -1537441.00% (disorted) | Weak |
ULBI outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Ultralife Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
46.81%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
15.61%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
634.01%
Industry Style: Cyclical, Value, Infrastructure
High Growth